cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2003; 42:1454-1459, doi:10.1016/S0735-1097(03)01042-8
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higgins, S. L.
Right arrow Articles by Yong, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, S. L.
Right arrow Articles by Yong, P. G.

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

Steven L. Higgins, MD, FACC*,*, John D. Hummel, MD, FACC{dagger}, Imran K. Niazi, MD, FACC{ddagger}, Michael C. Giudici, MD, FACC§, Seth J. Worley, MD, FACC||, Leslie A. Saxon, MD, FACC, John P. Boehmer, MD, FACC#, Michael B. Higginbotham, MD**, Teresa De Marco, MD, FACC, Elyse Foster, MD, FACC and Patrick G. Yong, MSEE{dagger}{dagger}

* Scripps Memorial Hospital, La Jolla, California, USA
{dagger} Riverside Methodist Hospital, Columbus, Ohio, USA
{ddagger} St. Luke's Presbyterian Hospital, Milwaukee, Wisconsin, USA
§ Genesis Medical Center, Davenport, Iowa, USA
|| Lancaster General Hospital, Lancaster, Pennsylvania, USA
University of California San Francisco Medical Center, San Francisco, California, USA
# The Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA
** Duke University School of Medicine, Durham, North Carolina, USA
{dagger}{dagger} Guidant Corporation, St. Paul, Minnesota, USA



View larger version (22K):

[in a new window]
 
Figure 1 Study design for each phase. Phase I (top) was a crossover design (n = 248); Phase II (bottom) was a parallel design (n = 333). CRT = cardiac resynchronization therapy; Rand = randomization time.

 


View larger version (15K):

[in a new window]
 
Figure 2 Kaplan-Meier curves for all-cause mortality (left) and all-cause mortality and heart failure (HF) hospitalization (right). CRT = cardiac resynchronization therapy.

 




 
  cardiology careers collections past issues search home